incretin hormone glp-1 Incretins as Multi–Disease State Treatments PDB-101: Molecule of the Month:

Wegovy has a well-established evidence base for obesity treatment, whereas topiramate carries significant neurological, metabolic, and teratogenic risks that make it unsuitable as a weight loss option

Efficacy and Safety of OnceWeekly Semaglutide Versus Once-Daily Insulin Glargine as Add On to Metformin (with or without Sulfonylureas) in Insulin-Naive Patients with Type 2 Diabetes (SUSTAIN 4): A Randomised, OpenLabel, Parallel-Group, Multicentre, Multinational, Phase 3a Trial

Breastfeeding is not recommended during treatment with Foundayo

For skin-driven double chins, these are far more appropriate than fat reduction alone